Covered recipient · General Payments record
ALYSSA MORRISH
Physician Assistants & Advanced Practice Nursing Providers Nurse Practitioner Family
General Payments · PY2021–2024
$903.29
- Reported across 40 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $421.97 | 16 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Acerta Pharma LLC | $116.03 | 2 |
| Ethicon US, LLC | $59.97 | 2 |
| TELA Bio, Inc. | $49.14 | 2 |
| ABBVIE INC. | $33.41 | 2 |
| VIVUS LLC | $31.24 | 2 |
| Tempus AI, Inc | $28.46 | 1 |
| Kerecis Limited | $23.57 | 1 |
| TerSera Therapeutics LLC | $23.41 | 1 |
| Merck Sharp & Dohme Corporation | $22.81 | 1 |
| Integra LifeSciences Corporation | $18.12 | 1 |
| AIMMUNE THERAPEUTICS, INC. | $15.81 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (16)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $13.56 | 01/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107696612 | CMS |
| ABBVIE INC. | $19.85 | 02/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107696614 | CMS |
| AIMMUNE THERAPEUTICS, INC. | $15.81 | 12/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1146996256 | CMS |
| AstraZeneca Pharmaceuticals LP | $19.99 | 01/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104288560 | CMS |
| AstraZeneca Pharmaceuticals LP | $96.04 | 08/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104520090 | CMS |
| Ethicon US, LLC | $20.15 | 08/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1077649142 | CMS |
| Ethicon US, LLC | $39.82 | 12/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1077649166 | CMS |
| Integra LifeSciences Corporation | $18.12 | 03/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1140142165 | CMS |
| Kerecis Limited | $23.57 | 09/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1120108057 | CMS |
| Merck Sharp & Dohme LLC | $22.81 | 07/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1141875618 | CMS |
| TELA Bio, Inc. | $28.42 | 02/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1154164136 | CMS |
| TELA Bio, Inc. | $20.72 | 05/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1154164134 | CMS |
| Tempus AI, Inc | $28.46 | 11/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1150184884 | CMS |
| TerSera Therapeutics LLC | $23.41 | 02/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1144719597 | CMS |
| VIVUS LLC | $16.03 | 02/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1129420629 | CMS |
| VIVUS LLC | $15.21 | 12/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1129420631 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2021, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2021 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.